Edinoff, A.N.; Nix, C.A.; Reed, T.D.; Bozner, E.M.; Alvarez, M.R.; Fuller, M.C.; Anwar, F.; Cornett, E.M.; Kaye, A.M.; Kaye, A.D.
Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose. Psychiatry Int. 2021, 2, 365-378.
https://doi.org/10.3390/psychiatryint2040028
AMA Style
Edinoff AN, Nix CA, Reed TD, Bozner EM, Alvarez MR, Fuller MC, Anwar F, Cornett EM, Kaye AM, Kaye AD.
Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose. Psychiatry International. 2021; 2(4):365-378.
https://doi.org/10.3390/psychiatryint2040028
Chicago/Turabian Style
Edinoff, Amber N., Catherine A. Nix, Tanner D. Reed, Elizabeth M. Bozner, Mark R. Alvarez, Mitchell C. Fuller, Fatimah Anwar, Elyse M. Cornett, Adam M. Kaye, and Alan D. Kaye.
2021. "Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose" Psychiatry International 2, no. 4: 365-378.
https://doi.org/10.3390/psychiatryint2040028
APA Style
Edinoff, A. N., Nix, C. A., Reed, T. D., Bozner, E. M., Alvarez, M. R., Fuller, M. C., Anwar, F., Cornett, E. M., Kaye, A. M., & Kaye, A. D.
(2021). Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose. Psychiatry International, 2(4), 365-378.
https://doi.org/10.3390/psychiatryint2040028
